Designed for Precision.
Developed for Life.

Adcendo ApS is a global clinical-stage biotech company dedicated to developing highly differentiated first and best-in-class antibody-drug conjugates (ADCs) for targeted treatment of cancer.

Adcendo is proud to have been named 2025 Biotech Company of the Year by Danish Bio

Latest News